Reflection of successful anticancer drug development processes in the literature

Heinemann F, Huber T, Meisel C, Bundschus M, Leser U.

Drug Discov Today. 2016 Nov 16

PMID: 27443674

Use of data mining at the Food and Drug Administration

Duggirala HJ, Tonning JM, Smith E, Bright RA, Baker JD, Ball R, Bell C, Bright-Ponte SJ, Botsis T, Bouri K, Boyer M, Burkhart K, Condrey GS, Chen JJ, Chirtel S, Filice RW, Francis H, Jiang H, Levine J, Martin D, Oladipo T, O'Neill R, Palmer LA, Paredes A, Rochester G, Sholtes D, Szarfman A, Wong HL, Xu Z, Kass-Hout T.

J Am Med Inform Assoc. 2016 Mar;23(2):428-34


Making sense of big data in health research: Towards an EU action plan

Auffray C, Balling R, Barroso I, Bencze L, Benson M, Bergeron J, Bernal-Delgado E, Blomberg N, Bock C, Conesa A, Del Signore S, Delogne C, Devilee P, Di Meglio A, Eijkemans M, Flicek P, Graf N, Grimm V, Guchelaar HJ, Guo YK, Gut IG, Hanbury A, Hanif S, Hilgers RD, Honrado Á, Hose DR, Houwing-Duistermaat J, Hubbard T, Janacek SH, Karanikas H, Kievits T, Kohler M, Kremer A, Lanfear J, Lengauer T, Maes E, Meert T, Müller W, Nickel D, Oledzki P, Pedersen B, Petkovic M, Pliakos K, Rattray M, I Màs JR, Schneider R, Sengstag T, Serra-Picamal X, Spek W, Vaas LA, van Batenburg O, Vandelaer M, Varnai P, Villoslada P, Vizcaíno JA, Wubbe JP, Zanetti G

Genome Med. 2016 Jun 23;8(1):71


PMC ID: PMC4919856

Application of automated natural language processing (NLP) workflow to enable a federated search of external biomedical content in drug discovery development

McEntire R, Szalkowski D, Butler J, Kuo MS, Chang M, Chang M, Freeman D, McQuay S, Patel J, McGlashen M, Cornell WD, Xu JJ.

Drug Discov Today. 2016 May; 21(5):826-35

PMID: 26979546

Developing Timely Insights on Comparative Effectiveness Research with a Text Mining Pipeline

Chang M, Chang M, Reed JZ, Milward D, Xu JJ, Cornell WD

Drug Discov Today. 2016 Mar; 21(3):473-80

PMID: 26854423


Comparative effectiveness research (CER) provides evidence for the relative effectiveness and risks of different treatment options and informs decisions made by healthcare providers, payers, and pharmaceutical companies.